IASLC Tobacco Declaration: IASLC Statement on Tobacco Control and Smoking Cessation (English, Chinese, Japanese, Polish, Portuguese, Spanish)-Tobacco Declaration: Declaração da IASLC - Cessação do Tabagismo Após o Diagnóstico de Câncer

Tobacco Declaration: Declaração da IASLC - Cessação do Tabagismo Após o Diagnóstico de Câncer - Portuguese

Pdf Summary

The International Association for the Study of Lung Cancer (IASLC) emphasizes the importance of smoking cessation after a cancer diagnosis. Smoking, a known cause of cancer, continues to have harmful effects post-diagnosis, increasing mortality rates, cancer-related deaths, risks of new primary cancers, and treatment toxicity. Despite this, many cancer patients who smoke do not receive effective assistance with quitting. Healthcare providers need to address tobacco use in cancer patients to improve treatment outcomes. The IASLC recommends evaluating all cancer patients for smoking, providing evidence-based cessation support, including it in cancer education programs, ensuring reimbursement for cessation services, and including smoking status in clinical studies. Clinical trials for cancer patients should also focus on effective smoking cessation strategies.

Keywords

International Association for the Study of Lung Cancer

IASLC

smoking cessation

cancer diagnosis

tobacco use

cancer patients

treatment outcomes

evidence-based support

clinical trials

smoking cessation strategies